Membrane-permeable derivatives of cyclic AMP (cAMP) produced concentration-dependent increases in activity of tyrosine hydroxylase [L-tyrosine, tetrahydro-pteridine: oxygen oxidoreductase (3-hydroxylating), EC 1.14.16.21 in membrane-limited nerve endings (synaptosomes) prepared from three regions of rat brain. Increased hydroxylation occurred even after preincubation and removal of dibutyryl cyclic AMP. In all brain regions, the hydroxylation of phenylalanine and tyrosine was increased, but dibutyryl cAMP had little effect on activity of tryptophan hydroxylase, no effect on aromatic amino-acid decarboxylase, on uptake of tyrosine or phenylalanine, uptake or efflux of dopamine, or distribution of hydroxylase between cytoplasmic and particulate components of the synaptosomes. Dibutyryl cAMP decreased inhibition of catecholamine synthesis in synaptosomes by dopamine and apomorphine. In a soluble preparation of striatal tyrosine hydroxylase, activity was increased by addition of lower concentrations of cAMP or dibutyryl cAMP than with unbroken nerve endings, when subsaturating concentrations of tyrosine and cofactor were employed, while butyrate, chloride, 5'-AMP, ADP, ATP, and cyclic GMP had no activating effect, Increased activity of soluble tyrosine hydroxylase was reflected in increased affinity (Kin) for substrate and cofactor and decreased affinity (KJ) for inhibitory end-product (dopamine), suggesting a change in the physical-chemical state of the enzyme or an activator molecule. Cyclic AMP may activate tyrosine hydroxylase during periods of increased neuronal activity.
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Some effects of dopamine and norepinephrine as neurotransmitters may be mediated by their activation of adenylate cyclase to increase cellular concentrations of cyclic 3': 5'-adenosine monophosphate (cyclic AMP). Catecholamines stimulate the production of cyclic AMP in the pineal gland (1), superior cervical ganglion (2), retina (3) , and in slices (4, 5) or homogenates (6, 7) of portions of the brain. Neurophysiological depressant effects of catecholamines on neurons of brain (8, 9) and sympathetic ganglia (10) can be mimicked by exogenous cyclic AMP. Thus, cyclic AMP may act postsynaptically in mediating adrenergic neurotransmission. Dibutyryl cyclic AMP stimulates release of norepinephrine from the hypogastric nerve-vas deferens preparation (11) and adrenal medulla (12 (19) (20) (21) (22) (23) . Synaptosomal preparations were incubated in a Krebs-Ringer phosphate medium buffered at pH 6.7, the optimum for this assay in synaptosomes, as described previously (20) (21) (22) . In all experiments, protein was determined by the method of Lowry et al. (24) . Tyrosine hydroxylase was assayed by measurement of the rate of formation of 14CO2 from excess (20 ;zM) i-[carboxy-14C]tyrosine (New England Nuclear) as substrate, as described in detail previously (21, 22 In some experiments, synaptosomes (P2) were lysed by osmotic shock in 10 mM sodium phosphate buffer, pH 7.0, and tyrosine hydroxylase in the 48,000 X g supernatant and pellet was assayed by the production of [3H ]water by incubation with i, [3,5-3H ] tyrosine (New England Nuclear) and 1 mM 6,7-dimethyl-5,6,7,8-tetrahydropterin (Me2PtnH4, Calbiochem) as described elsewhere (19, 20, 22) .
Assay of Soluble Tyrosine Hydroxylase. Soluble tyrosine hydroxylase activity was assayed in a 100,000 X g supernatant extract of striatal tissues homogenized in 50 mM Tris-acetate buffer, pH 6.0, by a modification of the method of Shiman et al. (25) described elsewhere in detail (17, 26, 27) . The soluble extracts (50-70 Ag of protein) 'were preincubated for 5 min and incubated after addition of substrate for 45 min in 1.0 ml of medium containing partially purified sheep liver pteridine reductase (70 Ag of protein-a 10-fold excess over the amount required for maximal tyrosine hydroxylase activity), NADPH (1 mM), catalase (3300 units), sodium acetate buffer, pH 6.0 (50 mM), and various concentrations of Me2PtnH4 or tetrahydrobiopterin (bPtnH4, donated by Roche Products, Ltd. of England) and i- [3,5-3H ] tyrosine. Sheep hepatic dihydropteridine reductase was partially purified through the second ammonium sulfate fractionation step by the method of Kaufman (28) . "Blanks" consisted of either boiled striatal extract (20 min at 1000) or complete mixtures to which 50
Ml of glacial acetic acid had been added.
Kinetics were evaluated under conditions in which the reaction was found to be linearly dependent on time (for 45 min) and protein concentration (50-70 Mg). Values for ap- (29) by the method of Wilkinson (30) . The inhibitory constant for dopamine (Ks) was determined by the method of Dixon (31) (25) . In contrast, incubation with Bt2cAMP did not alter the activity of synaptosomal tryptophan hydroxylase in brain stem or cortex, and only slight activation was produced in the striatum. When whole-brain P2 fractions were incubated with Bt2cAMP (1 mM) and labeled tryptophan, the initial (0.5-5.0 min) uptake of tryptophan (1 MAM or 1 mM) into synaptosomes selectively trapped on Millipore filters (23) was increased (111 5 and 113 5% of control at 1 MAM and 1 mM tryptophan, respectively, at 0.5 min, with a similar increase at 5 min). Thus, the small increase in striatal tryptophan hydroxylation may be due to a small nonspecific effect of Bt2-cAMP on indoleamine neurons resulting in enhanced uptake of tryptophan.
The uptake of labeled tyrosine and phenylalanine was also studied in synaptosomes prepared (23) 10 ,uM cAMP (Fig. 1) , without any alteration in the apparent maximum velocity (Vmax). By applying Dixon kinetic analysis (31), 3-fold and 7-fold increases in the inhibitory constants (Ki) for dopamine were observed with Bt2cAMP and cAMP, respectively (Fig. 2) , suggesting a decreased affinity of tyrosine hydroxylase for dopamine. A similar change was obtained in the apparent Km for Me2PtnH4, which was decreased about 4-or 8-fold in the presence of Bt2cAMP or cAMP, respectively, without significant alterations in the apparent VmS, (Table 3) . Cyclic AMP was likewise found to decrease the apparent Km for bPtnH4 (Table 3) , which may be the natural endogenous (from 1.0 A: 0.2 to 3.0 A: 0.3 ,uM). A similar increase was ohcofactor of tyrosine, hydroxylase (20, 25) . One of these findings is that cAMP activates tyrosine hydroxylase through increased affinities of the enzyme for substrate (tyrosine) and its pteridine cofactor and a decreased affinity for inhibitory end-products, catecholamines.
The physiological significance of activation of tyrosine hydroxylase by cAMP in the regulation of catecholamine synthesis in vivo is not yet known. Cyclic AMP might activate tyrosine hydroxylase during periods of increased neuronal activity in central and peripheral adrenergic neurons. In fact, a recent study employing the hypogastric nerve-vas deferens preparation demonstrated that Me2PtnH4 did not reduce the difference in norepinephrine synthesis between stimulated and sham-stimulated preparations (33) . These results were interpreted as suggesting that the increased synthesis of catecholamines from tyrosine associated with acute nerve stimulation is not simply the consequence of reduced end-product feedback inhibition secondary to the release of catecholamines, and that other effects may also contribute, including perhaps the production of a positive allosteric effector during nerve stimulation, which increases the tyrosine hydroxylase activity (33) . More recent experiments have also demonstrated that electrical stimulation of the guinea pig hypogastric nerve-vas deferens preparation (27) as well as of locus coeruleus-hippocampal noradrenergic (34) , and of nigro-striatal dopaminergic (35) neurons in the rat brain causes an activation of soluble tyrosine hydroxylase. These instances of increased activity of neuronal tyrosine hydroxylase following nerve stimulation, at least in brain tissue (34, 35) , and possibly (27) , though not necessarily (33) , in the vas deferens, appear to be mediated by an increased affinity of tyrosine hydroxylase for both substrate and cofactor and a decreased affinity for inhibitory end-products. These results are similar to the effects we observed with cAMP (Table 3, Figs. 1 and 2 ).
Thus, in view of these effects of cAMP on the kinetics of tyrosine hydroxylase and the observations that both electrical stimulation and depolarizing agents can produce increased concentrations of cAMP in brain slices (36, 37) , cAMP might play a role as an activator of tyrosine hydroxylase during neuronal depolarization, particularly on prolonged stimulation requiring increased synthesis of catecholamines and increased availability of newly synthesized, readily releasable catecholamines. Since the present effects of cyclic AMP on tyrosine hydroxylase occurred within 5 min and did not inProc. Nat. Acad. Sci. USA 72 (1975) Brain Tyrosine Hydroxylase Activated by Cyclic AMP 793 volve an increase in the apparent maximum velocity of the reaction, it is evidently not similar to the previously reported ability of cAMP to induce increases in levels of tyrosine hydroxylase and other enzymes involved in the metabolism of catecholamines in organ cultures of sympathetic ganglia by a process requiring protein synthesis (38) . The activation of soluble striatal tyrosine hydroxylase by cAMP that we observed may be a result of a direct, allosteric activation of tyrosine hydroxylase by cAMP which is reflected in an increased affinity of the enzyme for both substrate and cofactor and a decreased affinity for the inhibitory end-product, dopamine. However, since the activation of protein kinases appears at present to be a major mechanism by which cAMP mediates many of its important functions (39, 40) , it seems probable that the mechanism underlying this effect might involve an activation of a brain cAMP-dependent protein kinase with subsequent phosphorylation of either tyrosine hydroxylase itself or an activator of this enzyme.
